You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 18, 2024

~ Buy the CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (benzoyl peroxide; clindamycin phosphate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Clindamycin Phosphate And Benzoyl Peroxide, and what generic alternatives are available?

Clindamycin Phosphate And Benzoyl Peroxide is a drug marketed by Actavis Labs Ut Inc, Chartwell Rx, Encube, Glenmark Pharms, Mylan Pharms Inc, Padagis Israel, Taro, and Zydus Pharms. and is included in fifteen NDAs.

The generic ingredient in CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is benzoyl peroxide; clindamycin phosphate. There are seventeen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; clindamycin phosphate profile page.

Summary for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Drug patent expirations by year for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Icahn School of Medicine at Mount SinaiPhase 2
Valeant Pharmaceuticals International, Inc.Phase 2
Bausch Health Americas, Inc.Phase 2

See all CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE clinical trials

Pharmacology for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

PATENT CHALLENGE
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 205128-001 Jun 19, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Pharms Inc CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 065443-001 Aug 11, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Encube CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 204087-001 Jun 27, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 208683-001 Jun 5, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.